Skip to main content
Caplight Logo









BioPhy

BioPhy

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.biophy.ai/

Last Round

Series A

Mar 20, 2025

Total Funding Raised

$11.1M

Company Overview

BioPhy is a healthcare technology company that provides an AI operating system to accelerate the identification and development of promising drug candidates.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Healthcare Analytics, Compliance & Risk, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial predictiondrug development AIpredictive analyticsbiotech AIpharma AIregulatory gap analysisclinical trial softwaredrug discovery platformbiomedical knowledge graphSaaSdrug development de-riskingAI-native pharmaclinical operationsgenerative AIAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioPhy Comparables

Compare BioPhy with similar companies based on industry and business-model similarity.

BioPhy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Intelligencia AI
89%
PhaseV
86%
QuantHealth
81%

BioPhy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 20, 2025
Pre SeedNov 7, 2023

Key People

Founding team and executive leadership

Daniel Sciubba

Co-founder, Chief Medical Officer

Founding Team

Dave Latshaw

Co-Founder, Chief Executive, Chief Scientist

Founding Team

Steven Truong

Co-Founder, President and CFO

Founding Team

BioPhy Investors

Notable investors and investment history

BioPhy investors
InvestorRounds
Audere CapitalPre Seed
MetrodoraPre Seed
TRCM FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Grew 38% QoQ, from 8 to 11 employees.

  • Mar 20, 2025

    $7M round completed.

BioPhy Filings

Explore SEC and related filing metadata, where available.

BioPhy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioPhy's valuation, stock price, and market status.

Is BioPhy a public or private company?

BioPhy is a private company.

What is the current stock price of BioPhy?

BioPhy is a private company with no public stock price. No recent secondary market data is available.

How much is BioPhy worth (valuation)?

Valuation information for BioPhy is not publicly available.

Can I buy BioPhy stock?

BioPhy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioPhy's last funding round?

BioPhy's most recent funding round was Series A on March 20, 2025.

Who are the main investors in BioPhy?

Key investors in BioPhy include Audere Capital.

Will BioPhy IPO soon?

No public IPO plans have been announced for BioPhy.

How can I track BioPhy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioPhy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range11
Year Founded2020
Last FundingMar 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?